Skip to header Skip to main navigation Skip to main content Skip to footer
Home
Academic Citations from Palestine
Foregrounding the Research of Academics in Palestine

Main navigation

  • Home
  • Search
  • About

Efficacy and Safety of Latiglutenase in the Treatment of Celiac Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Blank
Al-Azhar University – Gaza
Jaber F.; Ayyad M.; Alsakarneh S.; Jaber M.; Alselek A.; Adam M.; Gangwani M.K.; Ali H.; Dahiya D.S.
Jaber, Fouad (57927659200); Ayyad, Mohammed (57226576955); Alsakarneh, Saqr (57919358400); Jaber, Mohammad (58774780400); Alselek, Anas (59335043800); Adam, Mohammad (59208191800); Gangwani, Manesh Kumar (57196117639); Ali, Hassam (57221081047); Dahiya, Dushyant Singh (57219722138)
57927659200; 57226576955; 57919358400; 58774780400; 59335043800; 59208191800; 57196117639; 57221081047; 57219722138
2024
American Journal of Therapeutics
Efficacy and Safety of Latiglutenase in the Treatment of Celiac Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
31
5
e614
e618
Lippincott Williams and Wilkins
Department of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States; Faculty of Medicine, Al-Quds University, Jerusalem, Palestine; Department of Medicine, Al-Azhar University, Faculty of Medicine, Gaza, Palestine; Faculty of Medicine, Cairo University, Cairo, Egypt; Department of Internal Medicine, University of Toledo, Toledo, OH, United States; Department of Gastroenterology, ECU Health Medical Center, Greenville, NC, United States; Division of Gastroenterology Hepatology & Motility, The University of Kansas School of Medicine, Kansas City, KS, United States
Jaber F., Department of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States; Ayyad M., Faculty of Medicine, Al-Quds University, Jerusalem, Palestine; Alsakarneh S., Department of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States; Jaber M., Department of Medicine, Al-Azhar University, Faculty of Medicine, Gaza, Palestine; Alselek A., Faculty of Medicine, Cairo University, Cairo, Egypt; Adam M., Department of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States; Gangwani M.K., Department of Internal Medicine, University of Toledo, Toledo, OH, United States; Ali H., Department of Gastroenterology, ECU Health Medical Center, Greenville, NC, United States; Dahiya D.S., Division of Gastroenterology Hepatology & Motility, The University of Kansas School of Medicine, Kansas City, KS, United States
1
10.1097/MJT.0000000000001755
Celiac Disease; Humans; Protein Glutamine gamma Glutamyltransferase 2; Randomized Controlled Trials as Topic; Transglutaminases; Treatment Outcome; CD3 antigen; latiglutenase; protein glutamine gamma glutamyltransferase; protein glutamine gamma glutamyltransferase 2; abdominal distension; adult; celiac disease; cell density; controlled study; diarrhea; digestive tract parameters; drug efficacy; drug safety; fatigue; headache; human; intraepithelial lymphocyte; Letter; meta analysis; nausea; phase 2 clinical trial (topic); randomized controlled trial (topic); systematic review; villous height to crypt depth ratio; celiac disease; immunology; randomized controlled trial (topic); treatment outcome